RepliCel is built on its unparalleled scientific knowledge of the unique biological characteristics of hair follicle cells and its technical, clinical and commercial expertise to develop, manufacture and deliver propriety products designed to address specific cell deficits or loss of cellular function resulting in chronic health conditions. The company is primarily targeting conditions in the orthopedic, dermatology, and aesthetic markets. The company develops products to be commercialized in collaboration with partners who have proven expertise in the applicable markets.

RepliCel is currently developing two unique biologic products (cell therapies) and a medical device (injector).